Can the expected medical device shortages in Germany be stopped?
Serious medical device shortages in Germany have been observed – and more are expected – as a consequence of the new EU
German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
Serious medical device shortages in Germany have been observed – and more are expected – as a consequence of the new EU
Since 2020, clinicians can prescribe – and SHI funds will reimburse – medical apps and digital health treatments, the so-called “DiGAs”. The BfArM assesses these DiGAs
Following on from the EU regulation for medical devices (MDR) that came into force over one year ago, this week I am
Hi again! This week I am switching it up a bit, and look at medical devices, particularly the EU regulation for medical
Hello again, and welcome to the second post in the 3-part series on reimbursement. Last week, we focused on the reimbursement of
Manufacturers of drugs or medical devices can apply for a consultation meeting with the G-BA before submitting a dossier. This consultation offers
The BfArM assesses medical apps and digital health treatments (DiGA) in terms of patient benefit, positive effects on care, data protection and
On 19 Dec 2019, the DVG came into force in Germany. This meant that since 2020, clinicians can prescribe and SHI funds
Before a new diagnostic and treatment method can be offered and reimbursed in the outpatient sector, two important steps need to be
The G-BA, physicians, hospitals, SHI funds or patient organizations can request the assessment of a new method. If the request was accepted,